BRYAN E ROBERTS
CIK 1239242 · last filed 2023-06-16
"Disclosed insider exposure" sums this person's most-recently-reported share counts across each company they're an insider in, multiplied by the current underlying price. It is not net worth — it misses retail holdings, private investments, real estate, index funds, and any company where the person isn't an SEC-reporting insider. For informational purposes only.
Loading insider history…
Disclosed Exposure
$176.65M
Companies
9
Total Filings
94
Lifetime Open-Market Net
-$223.70M
Holdings By Company
Latest on-record share count from this person's most recent non-derivative Form 4 transaction in each company. Disclosed exposure = shares × current underlying price.
| Symbol | Role | Shares | Price | Disclosed Exposure | Lifetime OM Net | Filings | Latest Filed |
|---|---|---|---|---|---|---|---|
| TXG | Director | 3,878,925 | $45.47 | $176.37M | -$218.40M | 13 | 2023-06-16 |
| CASTLIGHT HEALTH, INC. (CSLT) Delisted | Director | 0 | $2.05 | $0 | $4.79M | 16 | 2022-02-18 |
| Achaogen, Inc. (AKAO) Delisted | Director | 637,675 | — | — | $0 | 6 | 2018-06-07 |
| Vitae Pharmaceuticals, Inc (VTAE) Delisted | Director | 275,450 | — | — | $6.18M | 4 | 2016-05-27 |
| Zeltiq Aesthetics Inc (ZLTQ) Delisted | Director | 5,786 | — | — | -$3.05M | 11 | 2015-11-04 |
| IRWD | Director | 71,951 | $3.85 | $277.0K | -$13.16M | 35 | 2015-06-16 |
| ATHENAHEALTH INC (ATHN) Delisted | Director | 50 | $9.59 | $480 | -$48.3K | 5 | 2009-05-26 |
| XENOPORT INC (XNPT) Delisted | Director | 20,279 | — | — | -$2.9K | 3 | 2007-06-01 |
| SIRNA THERAPEUTICS INC (RNAI) Delisted | Director | 0 | — | — | $0 | 1 | 2007-01-03 |
Recent Filings · Page 2 of 10
94 filingsInsider activity across all companies, newest first. Form 4 rows are post-trade confirmations (buys, sells, grants, exercises). Notice (144) rows are pre-trade notices of intent to sell restricted or control stock under Rule 144 — they may not all execute. Compare adjacent dates to see which notices became actual sales.
| Filed | Symbol | Action | Net Shares | Net $ | Link |
|---|---|---|---|---|---|
| 2020-06-05 | CASTLIGHT HEALTH, INC. (CSLT) Delisted | Grant (A) | +180,645 | $0 | EDGAR |
| 2020-05-22 | TXG | Mixed | −943,912 | -$241.80M | EDGAR |
| 2020-05-01 | TXG | Conv (C) | +1,931,737 | $0 | EDGAR |
| 2019-09-17 | TXG | Buy (P) | +300,000 | $11.70M | EDGAR |
| 2019-09-16 | TXG | Mixed | +300,000 | $11.70M | EDGAR |
| 2019-09-12 | TXG | Grant (A) | — | $0 | EDGAR |
| 2019-06-07 | CASTLIGHT HEALTH, INC. (CSLT) Delisted | Grant (A) | +44,164 | $0 | EDGAR |
| 2019-06-07 | CASTLIGHT HEALTH, INC. (CSLT) Delisted | Grant (A) | +3,998,534 | $0 | EDGAR |
| 2018-06-22 | CASTLIGHT HEALTH, INC. (CSLT) Delisted | Grant (A) | +32,183 | $0 | EDGAR |
| 2018-06-07 | Achaogen, Inc. (AKAO) Delisted | Grant (A) | — | $0 | EDGAR |
Form 4 codes: P = open-market purchase · S = open-market sale · A = grant/award · M = option exercise · F = tax withholding at vest · G = bona-fide gift · D = disposition to issuer · J = other (see filing footnote). Only P / S codes carry directional signal.
Notice (144 / 144/A): Form 144 is a notice of intent to sell restricted/control stock under Rule 144, filed before the sale; 144/A is an amendment. Many notices are pre-scheduled under Rule 10b5-1 plans. A Form 4 with code S typically follows within a few days when the planned sale executes; missing follow-up Form 4s suggest the notice was cancelled or modified.
Notice (144 / 144/A): Form 144 is a notice of intent to sell restricted/control stock under Rule 144, filed before the sale; 144/A is an amendment. Many notices are pre-scheduled under Rule 10b5-1 plans. A Form 4 with code S typically follows within a few days when the planned sale executes; missing follow-up Form 4s suggest the notice was cancelled or modified.